Rating Change
William Blair analysts initiated coverage on Revolution Medicines, Inc. (NASDAQ:RVMD) with a rating of Outperform on October 16, 2026.
new coverageNASDAQ:RVMD
William Blair Initiates Coverage on Revolution Medicines, Inc. (RVMD) with Outperform
William Blair analysts initiated coverage on Revolution Medicines, Inc. (NASDAQ:RVMD) with a rating of Outperform on October 16, 2026.
At publication ·
What changed
Revolution Medicines, Inc. (NASDAQ:RVMD) · new coverage
- Firm
- William Blair
- Rating
- Outperform
- Price at event
- $177.96
- Market capitalization
- $15.2B
At a glance
Key takeaways
- William Blair initiated coverage on Revolution Medicines (RVMD) with an Outperform rating on October 16, 2026.
- RVMD trades at $177.96 with a $15.2B market capitalization and gained 232.7% over the past 52 weeks.
Market Context
Revolution Medicines, Inc. operates in the Healthcare sector. The stock currently trades at $177.96 with a market capitalization of $15.2B. The stock has gained 232.7% over the past 52 weeks.
Analyst coverage from William Blair provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Revolution Medicines, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Revolution Medicines, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 16, 2026 | William Blair | Outperform | N/A |
| Oct 15, 2026 | Needham | Buy | N/A |
| Oct 14, 2026 | RBC Capital | Outperform | N/A |
| Oct 08, 2026 | RBC Capital | Outperform | N/A |
| Oct 07, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View RVMD Stock Page
Frequently Asked Questions
What does the Outperform rating mean for RVMD?
A rating of Outperform from William Blair reflects the analyst's outlook on Revolution Medicines, Inc. (NASDAQ:RVMD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RVMD forecast page.